Page last updated: 2024-10-30

lorglumide and Aortic Arteritis, Giant Cell

lorglumide has been researched along with Aortic Arteritis, Giant Cell in 1 studies

lorglumide: RN given refers to (+-)-isomer
lorglumide : A racemate comprising equal amounts of (R)- and (S)-lorglumide.
N(2)-(3,4-dichlorobenzoyl)-N,N-dipentyl-alpha-glutamine : A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-(3,4-dichlorobenzoyl)glutamic acid with the amino group of dipentylamine.

Research Excerpts

ExcerptRelevanceReference
"Lorglumide was able to inhibit the functional responses elicited by exogenous CCK administration in both pancreas, stomach and gallbladder, while deramciclane was not effective under such circumstances."1.30Effect of deramciclane, a new 5-HT receptor antagonist, on cholecystokinin-induced changes in rat gastrointestinal function. ( Burghardt, B; Gacsályi, I; Kordás, K; Szénási, G; Varga, G, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Varga, G1
Kordás, K1
Burghardt, B1
Gacsályi, I1
Szénási, G1

Other Studies

1 other study available for lorglumide and Aortic Arteritis, Giant Cell

ArticleYear
Effect of deramciclane, a new 5-HT receptor antagonist, on cholecystokinin-induced changes in rat gastrointestinal function.
    European journal of pharmacology, 1999, Feb-19, Volume: 367, Issue:2-3

    Topics: Animals; Camphanes; Cholecystokinin; Digestive System; Gallbladder Emptying; Gastric Emptying; Giant

1999